A nurse is teaching a client who is newly diagnosed with Alzheimer's disease and their family about newly prescribed medications for Alzheimer's disease. Which statement by the client indicates the teaching was effective?

A. Marfan's syndrome: Marfan's syndrome is a genetic disorder that affects the connective tissue in the body, predisposing individuals to various cardiovascular, skeletal, and ocular abnormalities. While Marfan's syndrome can present with certain cranial and intracranial manifestations, such as dural ectasia and intracranial aneurysms, it is not typically considered a direct risk factor for traumatic brain injury (TBI).

B. Hypercarbia: Hypercarbia refers to elevated levels of carbon dioxide (CO2) in the blood. While severe hypercarbia can lead to cerebral vasodilation and potentially exacerbate intracranial pressure in individuals with traumatic brain injury, it is not considered a direct risk factor for TBI itself.

C. Falls: Falls are a significant risk factor for traumatic brain injury (TBI), particularly in older adults and young children. Falls can occur due to various factors such as environmental hazards, impaired mobility, balance issues, or neurological conditions. Falls are a leading cause of TBI-related emergency department visits, hospitalizations, and fatalities.

D. Ventriculostomy: Ventriculostomy involves the placement of a catheter into the ventricular system of the brain to monitor intracranial pressure (ICP) or drain cerebrospinal fluid (CSF). While ventriculostomy is a procedure commonly performed in the management of severe traumatic brain injury to monitor and manage intracranial pressure, it is not a risk factor for TBI itself.

A. Colchicine:

Colchicine is commonly used in the treatment of pericarditis, especially in cases of recurrent or refractory pericarditis.

It helps reduce inflammation and alleviate symptoms by inhibiting the migration of neutrophils to the inflamed pericardium.

Colchicine is often used in conjunction with nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids for the management of pericarditis.

B. Acetaminophen:

Acetaminophen is a pain reliever and fever reducer commonly used to manage mild to moderate pain associated with various conditions, including pericarditis.

While acetaminophen may provide symptomatic relief, it is not typically considered a primary treatment for pericarditis, especially in cases of severe or recurrent pericarditis.

C. Indomethacin:

Indomethacin is a nonsteroidal anti-inflammatory drug (NSAID) that can help reduce inflammation and relieve pain associated with pericarditis.

NSAIDs are often used as first-line therapy for acute pericarditis to alleviate symptoms such as chest pain and fever.

However, caution should be exercised when using NSAIDs in certain populations, such as older adults or those with preexisting gastrointestinal or renal conditions.

D. Amiodarone:

Amiodarone is an antiarrhythmic medication used to treat various types of arrhythmias, including ventricular arrhythmias and atrial fibrillation.

While pericarditis may lead to certain arrhythmias, such as atrial fibrillation, amiodarone is not a first-line treatment for pericarditis itself.

However, it may be used in cases where pericarditis is complicated by arrhythmias or concomitant cardiac conditions.

E. Nitroglycerine:

Nitroglycerine is a vasodilator medication commonly used to treat angina and heart failure.

While pericarditis may cause chest pain similar to angina, nitroglycerine is not typically used as a primary treatment for pericarditis.

In fact, nitroglycerine may exacerbate symptoms of pericarditis by causing venodilation and increasing cardiac preload.